Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 18, Issue 2, Pages 143-152
Publisher
SAGE Publications
Online
2012-02-06
DOI
10.1177/1352458511435105
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Idiopathic NBIA - clinical spectrum and transcranial sonography findings
- (2011) N. Brüggemann et al. EUROPEAN JOURNAL OF NEUROLOGY
- Meta-analysis of bone marrow transplantation treatment studies: mixing ‘apples and oranges’
- (2011) Mark S. Freedman et al. Multiple Sclerosis Journal
- Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
- (2011) P. Vermersch et al. NEUROLOGY
- Anti-JC virus antibodies: Implications for PML Risk Stratification
- (2010) Leonid Gorelik et al. ANNALS OF NEUROLOGY
- Characterization of JC human polyomavirus infection in a Portuguese population
- (2010) Ana Matos et al. JOURNAL OF MEDICAL VIROLOGY
- Discrepant findings in immune responses to JC virus in patients receiving natalizumab
- (2010) Chen S Tan et al. LANCET NEUROLOGY
- Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases
- (2010) David B Clifford et al. LANCET NEUROLOGY
- Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis
- (2010) Chen S Tan et al. LANCET NEUROLOGY
- Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies
- (2009) Eugene O. Major Annual Review of Medicine
- Progressive multifocal leukoencephalopathy: A national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases
- (2009) Eamonn S. Molloy et al. ARTHRITIS AND RHEUMATISM
- Prevalence of Polyomavirus BK and JC Infection and Replication in 400 Healthy Blood Donors
- (2009) Adrian Egli et al. JOURNAL OF INFECTIOUS DISEASES
- Progressive multifocal leukoencephalopathy in HIV-1 infection
- (2009) Paola Cinque et al. LANCET INFECTIOUS DISEASES
- Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project
- (2009) Kenneth R Carson et al. LANCET ONCOLOGY
- Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab
- (2009) Werner Wenning et al. NEW ENGLAND JOURNAL OF MEDICINE
- Progressive Multifocal Leukoencephalopathy after Natalizumab Monotherapy
- (2009) Hans Lindå et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adaptive Mutations in the JC Virus Protein Capsid Are Associated with Progressive Multifocal Leukoencephalopathy (PML)
- (2009) Shamil R. Sunyaev et al. PLoS Genetics
- Seroepidemiology of Human Polyomaviruses
- (2009) Jaime M. Kean et al. PLoS Pathogens
- Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies
- (2008) L. H. Calabrese et al. ANNALS OF THE RHEUMATIC DISEASES
- JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?
- (2008) J Verbeeck et al. GUT
- New cases of progressive multifocal leukoencephalopathy after treatment with natalizumab
- (2008) Hans-Peter Hartung LANCET NEUROLOGY
- Quantitative risk-benefit analysis of natalizumab
- (2008) J. P. Thompson et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started